CDKN2A and neoplasm: While this is supported by other studies that demonstrated p16-negative tumours on IHC had a high negative predictive value for CDKN2A HD in adult and paediatric morphologic glioblastomas [59], other studies reported p16/CDKN2A discordance with the IHC method [28].